HIV Vaccine Translational Research Laboratory

three-male-india-lab-scientistsGagandeep/IAVIThe HIV Vaccine Translational Research Laboratory is a research facility at the Government of India’s Translational Health Science and Technology Institute (THSTI) in the National Capital Region of New Delhi, India. 

The laboratory is a joint venture of IAVI and THSTI, which is an autonomous institute of the Department of Biotechnology.

The mission of the Laboratory is to develop strategies to accelerate the design and evaluation of HIV immunogens—the active ingredients of vaccines—in preclinical studies. Its ultimate aim is to design vaccines to prevent HIV infection, particularly vaccines that elicit an immune response capable of neutralizing a broad spectrum of HIV variants.

The Laboratory’s operations are coordinated with those of IAVI’s AIDS Vaccine Design and Development Laboratory in New York, which coordinates all IAVI-supported vaccine design efforts, and the IAVI Neutralizing Antibody Center at The Scripps Research Institute in California, which serves as the headquarters of the Neutralizing Antibody Consortium (NAC).